The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
By A Mystery Man Writer
Description
Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
IJMS, Free Full-Text
Pharos : Target Details - LTK
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC
Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities. - Abstract - Europe PMC
Lung cancer in patients who have never smoked — an emerging disease
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions
Lung cancer in patients who have never smoked — an emerging disease
from
per adult (price varies by group size)